Funding Details
- Awarder
- YCombinator
- Date Award
- May 01, 2019
- Vertical
- Healthcare,Drug Discovery and Delivery
- Funding URL
- View Funding Page
- Valuation
-
$0
Company Info
- Founding Year
- 2019
- Company Description
- Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.
- Market
- Healthcare
- Location
-
Boulder,
CO,
USA
- Coinvestors
- YCombinator
Links